{"id":4793,"date":"2001-09-01T14:58:09","date_gmt":"2001-09-01T13:58:09","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=4793"},"modified":"2014-06-11T16:58:29","modified_gmt":"2014-06-11T16:58:29","slug":"1st-ias-conference-on-hiv-pathogenesis-and-treatment","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/4793","title":{"rendered":"1st IAS Conference on HIV Pathogenesis and Treatment, July 8-11 2001, Buenos Aires, Argentina"},"content":{"rendered":"<p><strong><a href=\"https:\/\/i-base.info\/htb\/keyword\/ias-1-buenos-aires-2001\">Reports from the conference<\/a><\/strong><\/p>\n<ul>\n<li><a title=\"Permanent link to Lipodystrophy and metabolic complications\" href=\"https:\/\/i-base.info\/htb\/4790\" rel=\"bookmark\">Lipodystrophy and metabolic complications<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Lipodystrophy and metabolic disturbances\" href=\"https:\/\/i-base.info\/htb\/4787\" rel=\"bookmark\">Lipodystrophy and metabolic disturbances<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Pharmacology at 1st IAS\" href=\"https:\/\/i-base.info\/htb\/4785\" rel=\"bookmark\">Pharmacology at 1st IAS<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Drug-drug interactions\" href=\"https:\/\/i-base.info\/htb\/4782\" rel=\"bookmark\">Drug-drug interactions<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Entry inhibitor updates from the 1st IAS\" href=\"https:\/\/i-base.info\/htb\/4778\" rel=\"bookmark\">Entry inhibitor updates from the 1st IAS<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Structured treatment interruptions (STIs) and structured intermittent therapy (SITs)\" href=\"https:\/\/i-base.info\/htb\/4776\" rel=\"bookmark\">Structured treatment interruptions (STIs) and structured intermittent therapy (SITs)<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Adverse events with antiretrovirals\" href=\"https:\/\/i-base.info\/htb\/4771\" rel=\"bookmark\">Adverse events with antiretrovirals<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Reports from the conference Lipodystrophy and metabolic complications Lipodystrophy and metabolic disturbances Pharmacology at 1st IAS Drug-drug interactions Entry inhibitor updates from the 1st IAS Structured treatment interruptions (STIs) and structured intermittent therapy (SITs) Adverse events with antiretrovirals<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[12,89],"class_list":["post-4793","post","type-post","status-publish","format-standard","hentry","category-conference-reports","tag-conference-index","tag-ias-1st-2001"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/4793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=4793"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/4793\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=4793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=4793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=4793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}